Aspergillus fumigatus is the most prevalent airborne fungal pathogen, causing severe and usually fatal invasive infections in immunocompromised hosts. Success of anti-fungal therapy relies heavily on accuracy of diagnosis, but rapid and reliable detection of A. fumigatus remains difficult owing to the non-specific clinical symptoms and lack of distinct molecular targets. This proposal aims to utilize thermostable proteases secreted by A. fumigatus into the host environment as a target for the development of a novel fluorescence-based diagnostic assay for invasive aspergillosis. The applicant hypothesizes that fungal proteolytic activity can be detected in serum and BAL samples during invasive aspergillosis using a panel of Internally Quenched Fluorogenic Probes (IQFPs).
Aim 1 of the R21 phase will use a commercially available library of 360 IQFPs to optimize assay conditions for maximal detection of fungal proteolytic activity secreted in vitro. These conditions will then be used to test the feasibility of the assay for the detection of A. fumigatus in serum and BAL samples from animal models of infection (Source: IAAM contract).
In Aim 2, a panel of eight IQFPs with most promising diagnostic properties will be selected for targeted optimization in order to maximize sensitivity and selectivity. The R33 phase we will then evaluate the efficacy of this IQFP-based diagnostic platform for the detection of A. fumigatus proteases in clinical samples from human patients (Source: AsTeC contract). In addition, a comprehensive combinatorial library of 640,000 IQFPs will be assembled in order to expand the diagnostic applications to include the monitoring of antifungal therapy and the detection of different pathogenic moulds.

Public Health Relevance

A major obstacle to the effective treatment of invasive aspergillosis is the limited ability of current diagnostic methods to identify the infection, resulting in a high level of mortality. The goal of this study is to develop a novel diagnostic method that is based on the detection of fungal proteases that are secreted into host tissues during infection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AI085402-02
Application #
8011475
Study Section
Special Emphasis Panel (ZAI1-FDS-M (S1))
Program Officer
Ritchie, Alec
Project Start
2010-01-01
Project End
2011-12-31
Budget Start
2011-01-01
Budget End
2011-12-31
Support Year
2
Fiscal Year
2011
Total Cost
$198,399
Indirect Cost
Name
Sri International
Department
Type
DUNS #
009232752
City
Menlo Park
State
CA
Country
United States
Zip Code
94025
Jambunathan, Kalyani; Watson, Douglas S; Endsley, Aaron N et al. (2012) Comparative analysis of the substrate preferences of two post-proline cleaving endopeptidases, prolyl oligopeptidase and fibroblast activation protein ?. FEBS Lett 586:2507-12
Jambunathan, Kalyani; Watson, Douglas S; Kodukula, Krishna et al. (2012) Proteolytic fingerprinting of complex biological samples using combinatorial libraries of fluorogenic probes. Curr Protoc Protein Sci Chapter 21:Unit21.22
Watson, Douglas S; Feng, Xizhi; Askew, David S et al. (2011) Substrate specifity profiling of the Aspergillus fumigatus proteolytic secretome reveals consensus motifs with predominance of Ile/Leu and Phe/Tyr. PLoS One 6:e21001
Watson, Douglas S; Jambunathan, Kalyani; Askew, David S et al. (2011) Robust substrate profiling method reveals striking differences in specificities of serum and lung fluid proteases. Biotechniques 51:95-104